From the Centers for Disease Control and Prevention. FDA approval of a haemophilus b conjugate vaccine combined by reconstitution with an acellular pertussis vaccine.
D002648:Child; D002675:Child, Preschool; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage; D017277:Drug Approval; D018073:Haemophilus Vaccines / Q000008:administration & dosage; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D013745:Tetanus Toxoid / Q000008:administration & dosage; D014481:United States; D014486:United States Food and Drug Administration; D018074:Vaccines, Conjugate / Q000008:administration & dosage
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D018073:Haemophilus Vaccines; C055753:Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate; D013745:Tetanus Toxoid; D018074:Vaccines, Conjugate; C080881:diphtheria-tetanus-pertussis-haemophilus b conjugate vaccine